Published research is providing additional evidence of the effectiveness and safety of rapid-acting non-invasive brain stimulation therapy to treat people suffering from bipolar depression.
Read More
Research led by 2022 BBRF Young Investigator Sarah H. Sperry, Ph.D., of the University of Michigan, has led to her team’s development of an innovative method for assessing the course of bipolar…
Read More
Among young people under age 18 who are diagnosed with disorders on the bipolar spectrum (BD), as many as one in two attempts suicide. Of all psychiatric diagnoses in this age group, BD is associated…
Read More
A follow-up study of young adults who were diagnosed years earlier with childhood-onset bipolar disorder suggests that their cognitive flexibility—in many cases already impaired at the time of…
Read More
Cariprazine, a medicine approved by the FDA in 2015 for the treatment of manic episodes in bipolar I disorder, was effective in reducing depressive symptoms in bipolar I disorder patients in a phase…
Read More
